Cargando…

Pharmacokinetics of N,N-dimethyltryptamine in Humans

BACKGROUND AND OBJECTIVE: N,N-dimethyltryptamine (DMT) is a psychedelic compound under development for the treatment of major depressive disorder (MDD). This study evaluated the preclinical and clinical pharmacokinetics and metabolism of DMT in healthy subjects. METHODS: The physiochemical propertie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Good, Meghan, Joel, Zelah, Benway, Tiffanie, Routledge, Carol, Timmermann, Chris, Erritzoe, David, Weaver, Richard, Allen, Graham, Hughes, Charlotte, Topping, Helen, Bowman, Amy, James, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122081/ https://www.ncbi.nlm.nih.gov/pubmed/37086340 http://dx.doi.org/10.1007/s13318-023-00822-y

Ejemplares similares

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine – Implications for dose considerations
por: Eckernäs, Emma, et al.
Publicado: (2022)

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience
por: Lawrence, David Wyndham, et al.
Publicado: (2022)

N,N‐dimethyltryptamine affects electroencephalography response in a concentration‐dependent manner—A pharmacokinetic/pharmacodynamic analysis
por: Eckernäs, Emma, et al.
Publicado: (2023)

N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
por: James, Edward, et al.
Publicado: (2022)

Noncompetitive Inhibition of Indolethylamine-N-methyltransferase by N,N-Dimethyltryptamine and N,N-Dimethylaminopropyltryptamine
por: Chu, Uyen B., et al.
Publicado: (2014)

Reaction of N,N-Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions
por: Dunlap, Lee E., et al.
Publicado: (2018)

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain
por: Dean, Jon G., et al.
Publicado: (2019)

Optimized infusion rates for N,N‐dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework
por: Eckernäs, Emma, et al.
Publicado: (2023)

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
por: Szabo, Attila, et al.
Publicado: (2014)

Detection and Quantification of Psychoactive N,N-Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry
por: Chambers, Megan I., et al.
Publicado: (2020)

Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine
por: Dean, Jon G.
Publicado: (2018)

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
por: Barker, Steven A.
Publicado: (2022)

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo
por: Morales-Garcia, Jose A., et al.
Publicado: (2020)

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
por: Barker, Steven A.
Publicado: (2018)

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
por: Cameron, Lindsay P., et al.
Publicado: (2019)

Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
por: Brito-da-Costa, Andreia Machado, et al.
Publicado: (2020)

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
por: Reckweg, Johannes T., et al.
Publicado: (2022)

Acute Intoxication following Dimethyltryptamine Ingestion
por: Bilhimer, Matthew H., et al.
Publicado: (2018)

Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT(2A) Receptor by a Light‐Controllable N,N‐Dimethyltryptamine Derivative
por: Gerwe, Hubert, et al.
Publicado: (2022)

Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine
por: Silveira, Gabriela de Oliveira, et al.
Publicado: (2020)

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
por: Uthaug, Malin V, et al.
Publicado: (2019)

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
por: Ortiz Bernal, Ana María, et al.
Publicado: (2022)

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
por: Reckweg, Johannes, et al.
Publicado: (2021)

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N,N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
por: Reckweg, J., et al.
Publicado: (2022)

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
por: Reckweg, Johannes T., et al.
Publicado: (2023)

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
por: Szabo, Attila, et al.
Publicado: (2016)

Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the “God Molecule”
por: Al-Imam, Ahmed, et al.
Publicado: (2023)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells
por: Szabo, Attila, et al.
Publicado: (2016)

Review of robot-assisted partial nephrectomy in modern practice
por: Potretzke, Aaron M., et al.
Publicado: (2015)

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
por: Uthaug, M. V., et al.
Publicado: (2019)

Pharmacokinetic analysis of new synthetic antimalarial N-251
por: Okada, Kazuaki, et al.
Publicado: (2019)

Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide
por: Jiang, Jinfang, et al.
Publicado: (2016)

DMT Models the Near-Death Experience
por: Timmermann, Christopher, et al.
Publicado: (2018)

N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment
por: Mthiyane, Thuli, et al.
Publicado: (2020)

Pharmacokinetics of Oral Taurine in Healthy Volunteers
por: Ghandforoush-Sattari, Mohammadreza, et al.
Publicado: (2010)

Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients
por: Liang, Sitai, et al.
Publicado: (2014)

Population pharmacokinetics of brodalumab in patients with moderate to severe plaque psoriasis
por: Timmermann, Stine, et al.
Publicado: (2019)

The Pharmacokinetic Profile and Bioavailability of Enteral N-Acetylcysteine in Intensive Care Unit
por: Teder, Kersti, et al.
Publicado: (2021)

The N(th) Wave of COVID-19: Will It Be Alzheimer’s?
por: Weaver, Donald F.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r6g9mo4rvn5abt3c35eiguq4ev